RIYADH: US-based Insilico Medicine has raised an additional $35 million in a Series D funding round led by Aramco-backed Prosperity7 Ventures.
According to FierceBiotech, with this new round the total Series D financing has reached $95 million.
The funds will allow the company to expand its artificial intelligence platform into other areas such as sustainable chemistry, green energy and agriculture.
The financing brought in Prosperity7 Ventures as a new investor.
